Clinical trial · Observational
Retrospective Survey of Bone Fracture in Patients With Arimidex 1mg
Retrospective Survey of Bone Fracture in Post-Menopausal Breast Cancer Patients With Arimidex 1 mg as Adjuvant Therapy
NCT00859560CI-TRIAL-00002120completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The retrospective survey is to investigate the incidence of bone fracture in post-menopausal breast cancer patients with Arimidex 1mg, who were previously registered for the clinical experience investigation.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Bone fracture incidence
- timeFrame
- Time since starting Arimidex
Secondary outcomes (2)
- measure
- Survival
- timeFrame
- Time since starting Arimidex
- measure
- Bone density measurement
- timeFrame
- Time since starting Arimidex
Eligibility
Eligibility (as posted)
- Sex
- Female
Show eligibility criteria text
Inclusion Criteria: * Post-menopausal breast cancer patients treated with Arimidex 1mg at the time of previously conducted clinical experience investigation. Exclusion Criteria: \-
References
Publications (0)
Data not yet available
No reference posted for this study.